CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients Modifiable lifestyle factors and heart failure: A Mendelian randomization study Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection Fraction The multiple causes and treatments of heart failure: focus on genetic and molecular mechanisms and non-pharmacological interventions Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial

Consensus2019 Sep 6. pii: S0167-5273(19)32502-1.

JOURNAL:Int J Cardiol. Article Link

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus

Farmakis D, Agostoni P, Baholli L et al. Keywords: acute heart failure; advanced heart failure; dobutamine; inodilators; inotropes; levosimendan; milrinone; norepinephrine

FULL TEXT PDF